Amyloid Blocker, >=96% (HPLC)

Code: scp0017-5mg D2-231

Not available outside of the UK & Ireland.

Amino Acid Sequence

Ac-Gln-Lys-Leu-Val-Phe-Phe-NH2

General description

Amyloid plaques characteristic of the Alzheimer brain contain fibrils comp...


read more

Your Price
£187.00 5MG

Not available outside of the UK & Ireland.

Amino Acid Sequence

Ac-Gln-Lys-Leu-Val-Phe-Phe-NH2

General description

Amyloid plaques characteristic of the Alzheimer brain contain fibrils composed of amyloid β aggregates. Peptides, small organic molecules and nanoparticles can be used to bind or aggregate amyloid β (Aβ). They have been used as a strategy for the development of pharmaceutical approaches or agents to treat Alzheimer′s disease (AD). Short peptides containing the sequence KLVFF have been shown to bind specifically to the homologous region in Aβ and are used to prevent full length amyloid fibril formation.

assay≥95% (HPLC)
compositionPeptide Content, ≥75%
formlyophilized
storage conditionprotect from light
storage temp.−20°C
This product has met the following criteria: